Provider responses to a global budgeting system: The case of drug expenditures in Taiwan hospitals.
暂无分享,去创建一个
[1] C. Chen,et al. Impact of Provider Competition under Global Budgeting on the Use of Cesarean Delivery , 2018, Health services research.
[2] V. Fan,et al. Global Budget Payment , 2016, Inquiry : a journal of medical care organization, provision and financing.
[3] V. Fan,et al. Strategic Provider Behavior Under Global Budget Payment with Price Adjustment in Taiwan. , 2015, Health economics.
[4] J. Mechanick,et al. Parenteral Nutrition - The Sweet and Sour Truth. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[5] Pi-fem Hsu. Does a global budget superimposed on fee-for-service payments mitigate hospitals’ medical claims in Taiwan? , 2014, International Journal of Health Care Finance and Economics.
[6] Hsien-Ming Lien,et al. Hospital ownership and drug utilization under a global budget: a quantile regression analysis. , 2014, International health.
[7] Toshiaki Iizuka,et al. Physician Agency and Adoption of Generic Pharmaceuticals , 2011, The American economic review.
[8] Shou-Hsia Cheng,et al. Hospital response to a global budget program under universal health insurance in Taiwan. , 2009, Health policy.
[9] C. Hsieh,et al. Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan. , 2009, Journal of health economics.
[10] Hsien-Ming Lien,et al. Hospital ownership and performance: evidence from stroke and cardiac treatment in Taiwan. , 2008, Journal of health economics.
[11] C. Loh,et al. Changes in drug prescription utilization for diabetic and hypertensive outpatients after initiation of the National Health Insurance's Global Budget Program in Taiwan. , 2008, Medical science monitor : international medical journal of experimental and clinical research.
[12] R Jones,et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management , 2007, Gut.
[13] S. Laditka,et al. Providers' responses to global budgeting in Taiwan: what were the initial effects? , 2007, Health services management research.
[14] Toshiaki Iizuka,et al. Experts' Agency Problems: Evidence from the Prescription Drug Market in Japan , 2006, The Rand journal of economics.
[15] Daron Acemoglu,et al. Input and Technology Choices in Regulated Industries: Evidence from the Health Care Sector , 2006, Journal of Political Economy.
[16] J. Schreyögg. Physician Drug Budgets in Germany and Effects on Prescription Behaviour , 2006 .
[17] Kamryn T. Eddy,et al. A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder. , 2004, Clinical psychology review.
[18] Kamhon Kan,et al. The design of payment systems for physicians under global budget – an experimental study , 1998 .
[19] Yue-chune Lee,et al. Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996–2003 , 2012, PharmacoEconomics.
[20] Sebastian Schneeweiss,et al. European Healthcare Policies for Controlling Drug Expenditure , 2012, PharmacoEconomics.
[21] Hsien-Ming Lien,et al. Global budgets and provider incentives: hospitals' drug expenditures in Taiwan. , 2010, Advances in health economics and health services research.
[22] Y. Hsueh,et al. A National Survey of Physician-Compensation Arrangements at Hospitals in Taiwan , 2002 .